Abstract | BACKGROUND: MATERIALS AND METHODS: The lignans threo-4,4'-dihydroxy-3-methoxylignan, (-)- dihydroguaiaretic acid, 4'-hydroxy-3,3',4-trimethoxylignan, 3,3',4,4'-tetramethoxylignan, 4,4'-diacetyl-3,3'-dimethoxylignan, talaumidin, heliobuphthalmin, (-)-dihydro- cubebin, and hinokinin were evaluated for their ability to inhibit human cytomegalovirus (HCMV) IE- antigen expression in lung cancer cells (A549). RESULTS: Most of the evaluated compounds reduced IE- antigen expression of HCMV, the best result being obtained with 4,4'-dihydroxy-3-methoxylignan. However, a dose-dependent significant increase of IE- antigen expression was found for the derivative (-)- dihydrocubebin. CONCLUSION: The results of this study suggest that some of these lignans might be valuable as potential cancer chemopreventive agents.
|
Authors | Rozália Pusztai, Marta Abrantes, Julianna Serly, Julia Sherly, Noélia Duarte, Joseph Molnar, Maria-José U Ferreira |
Journal | Anticancer research
(Anticancer Res)
Vol. 30
Issue 2
Pg. 451-4
(Feb 2010)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 20332453
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- IE1 protein, cytomegalovirus
- Immediate-Early Proteins
- Lignans
- Plant Extracts
|
Topics |
- Adenocarcinoma
(drug therapy, pathology, virology)
- Antineoplastic Agents
(pharmacology)
- Cell Survival
(drug effects)
- Cytomegalovirus
(drug effects)
- Cytomegalovirus Infections
(drug therapy, pathology, virology)
- Gene Expression Regulation, Viral
(drug effects)
- Humans
- Immediate-Early Proteins
(antagonists & inhibitors, metabolism)
- Immunoenzyme Techniques
- Lignans
(pharmacology)
- Lung Neoplasms
(drug therapy, pathology, virology)
- Myristicaceae
(chemistry)
- Plant Extracts
(chemistry, pharmacology)
- Tumor Cells, Cultured
|